WuXi Biologics
Offering End-to-End Solutions
WuXi Biologics offers extensive lead assessment and optimization services for antibody therapeutics such as monoclonal (mAb), bispecific (bsAb), and multispecific antibodies and other biologics. Our team of experts work with you to establish the best path in optimizing your molecule to its target and for its intended purpose.
WuXi Biologics offers antibody humanization using best fit approach combined with structure modeling for back-mutation design. 150+ humanization projects completed with >98% success rate.
Key features:
WuXi Biologics offers antibody affinity maturation through our well-established and highly-reliable parsimonious mutagenesis methodology. We can also offer phage library-based block-mutagenesis approach for affinity maturation of antibodies to cell-surface targets.
Key Features :
WuXi Biologics offers engineering of antibodies with different Fc variants
Related services: